Fresenius Medical Care (FMS) is rated a 'Buy,' citing strong fundamentals. FMS demonstrates robust revenue growth, margin expansion, and dividend safety, with a new HVHDF product rollout expected to ...
I am always looking for opportunities to cover new companies. Sometimes I find new companies that initially look interesting for investment, but after a closer look at the financials, it turns out ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results